No Data
No Data
RBC Capital Maintains Legend Biotech(LEGN.US) With Buy Rating, Maintains Target Price $84
Legend Biotech Price Target Maintained With a $84.00/Share by RBC Capital
RBC Capital Remains a Buy on Legend Biotech (LEGN)
Barclays Maintains Legend Biotech(LEGN.US) With Buy Rating, Maintains Target Price $94
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW) and Legend Biotech (LEGN)
Chinese concept stocks returning to the home market receive attention again: which companies have not yet returned and what is the scale of Holdings in US investment?
① How large is the scale of USA investors holding Chinese concept stocks? ② Which Chinese concept stock companies have not yet returned?